Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural, and biosecurity applications. The company offers Group B Streptococcus (GBS) rapid sensor, a diagnostic for the detection of human GBS in expectant mothers; kidney diseases, a POC tests for the screening, detection, and ongoing monitoring of various subsets of acute kidney injury and chronic kidney disease; bovine mastitis, a farm diagnostic to detect mastitis early which helps farmers; biosecurity pathogen tests, a portable sensor for frontline detection of invasive pests and pathogens -built for customs officers, farmers, and quarantine zones. The company was incorporated in 2021 and is based in Sydney, Australia.
NXN
NXN
NEXSEN LIMITED
Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural, and biosecurity applications. The company offers Group B Streptococcus (GBS) rapid sensor, a diagnostic for the detection of human GBS in expectant mothers; kidney diseases, a POC tests for the screening, detection, and ongoing monitoring of various subsets of acute kidney injury and chronic kidney disease; bovine mastitis, a farm diagnostic to detect mastitis early which helps farmers; biosecurity pathogen tests, a portable sensor for frontline detection of invasive pests and pathogens -built for customs officers, farmers, and quarantine zones.
Fundamentals
Historical Data9 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | — | — |
| 10 July | — | — |
| 9 July | — | — |
| 8 July | — | — |
| 7 July | — | — |
| 6 July | 0.02% | — |
Nexsen Limited (NXN) Short Interest Summary
Nexsen Limited (NXN) currently has 0.02% of its shares sold short (22 thousand shares, worth approximately $6K), based on ASIC short position data reported on 6 July 2026 (T+4 reporting lag). That makes NXN the #568 most shorted stock on the ASX most shorted list. NXN is part of the Health Care sector on the ASX.
Recent NXN Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 6 July 2026 | 0.02% | 0.0M | $0.26 |
NXN Short Selling — Frequently Asked Questions
What is Nexsen Limited (NXN)'s current short interest?
Nexsen Limited (NXN) currently has a short interest of 0.02% of total shares outstanding. This means 0.02% of NXN's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is NXN heavily shorted on the ASX?
NXN has a relatively low short interest of 0.02%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for NXN investors?
Short interest in NXN shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.02%, NXN's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this NXN short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for NXN.